MDGP (Medgroup) Notes Receivable: $0.00 Mil (As of Dec. 2094)


What is Medgroup Notes Receivable?

Medgroup MDGP Notes Receivable is $0.00 Mil as of Dec. 2094.

Medgroup's Notes Receivable for the quarter that ended in Dec. 2094 was $0.00 Mil.

Medgroup Notes Receivable Historical Data

* Premium members only.

The historical data trend for Medgroup's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medgroup Notes Receivable Chart

Medgroup Annual Data
Trend Mar90 Mar91 Mar92 Mar93 Mar94
Notes Receivable
0.00 0.00 0.00 0.00 0.00

Medgroup Quarterly Data
Mar90 Jun90 Sep90 Dec90 Mar91 Jun91 Sep91 Dec91 Mar92 Jun92 Sep92 Dec92 Mar93 Jun93 Sep93 Dec93 Mar94 Jun94 Sep94 Dec94
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Medgroup Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
Medgroup (MDGP) has a Notes Receivable of $0.00 Mil as of Dec. 2094. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Medgroup and its competitors.
Is Medgroup's Notes Receivable too high?
Medgroup's current Notes Receivable is $0.00 Mil.
How does Medgroup's Notes Receivable compare to USNU and ATMS?
Medgroup's Notes Receivable of $0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Healthcare Providers & Services company?
A good Notes Receivable depends on the Healthcare Providers & Services industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Medgroup and its competitors. Medgroup's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medgroup stock overvalued right now?
Medgroup (MDGP) has a current Notes Receivable of $0.00 Mil. The current Notes Receivable is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Medgroup (MDGP), the current Notes Receivable is $0.00 Mil as of Dec. 2094. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medgroup Business Description

Address 4430 Haskell Avenue, Suite 210, Encino, CA, USA, 91436
Medgroup Inc is a multi-specialty health care provider and serves the community with treating injuries and illness. Its facilities have diagnostic testing in computerized ROM, muscle testing, x-ray, EMG/NCV, EKG, laboratory and pharmacy.